Supplement to: Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

  • Salloway, S
  • Sperling, R
  • Fox, N C
New England Journal of Medicine 370(4), January 23, 2014.
Copyright © 2014 Massachusetts Medical Society. All rights reserved.
View full text|Download PDF